These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18239392)

  • 1. Atrial fibrillation following device closure of patent foramen ovale.
    Burow A; Schwerzmann M; Wallmann D; Tanner H; Sakata T; Windecker S; Meier B; Delacrétaz E
    Cardiology; 2008; 111(1):47-50. PubMed ID: 18239392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New onset atrial fibrillation after patent foramen ovale closure.
    Staubach S; Steinberg DH; Zimmermann W; Wawra N; Wilson N; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):889-95. PubMed ID: 19626689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke.
    Bronzetti G; D'Angelo C; Donti A; Salomone L; Giardini A; Maria Picchio F; Boriani G
    Int J Cardiol; 2011 Jan; 146(1):17-21. PubMed ID: 19487038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
    Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
    Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.
    Spies C; Khandelwal A; Timmermanns I; Schräder R
    Am J Cardiol; 2008 Oct; 102(7):902-6. PubMed ID: 18805119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
    Wahl A; Jüni P; Mono ML; Kalesan B; Praz F; Geister L; Räber L; Nedeltchev K; Mattle HP; Windecker S; Meier B
    Circulation; 2012 Feb; 125(6):803-12. PubMed ID: 22238228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of contemporary devices used for transcatheter patent foramen ovale closure.
    Spies C; Reissmann U; Timmermanns I; Schräder R
    J Invasive Cardiol; 2008 Sep; 20(9):442-7. PubMed ID: 18762672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
    Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.
    Bonvini RF; Sztajzel R; Dorsaz PA; Righini M; Bonvin C; Alibegovic J; Sigwart U; Camenzind E; Verin V; Sztajzel J
    Int J Stroke; 2010 Feb; 5(1):4-9. PubMed ID: 20088986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter closure of patent foramen ovale in older adults.
    Kiblawi FM; Sommer RJ; Levchuck SG
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):136-42; discussion 143-4. PubMed ID: 16755591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.
    Faggiano P; Frattini S; Piovesana P; Lorusso R; Chiari E; Scolari F; Padovani A; Cas LD
    Int J Cardiol; 2012 Apr; 156(1):47-52. PubMed ID: 21112103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
    Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of percutaneous device implantation for closure of patent foramen ovale on valve insufficiencies.
    Wöhrle J; Kochs M; Spiess J; Nusser T; Hombach V; Merkle N
    Circulation; 2009 Jun; 119(23):3002-8. PubMed ID: 19487592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A; Kunz M; Moschovitis A; Nageh T; Schwerzmann M; Seiler C; Mattle HP; Windecker S; Meier B
    Heart; 2008 Mar; 94(3):336-41. PubMed ID: 17639093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
    Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
    Kwong JS; Lam YY; Yu CM
    Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.